Dark Forest Capital Management’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Dark Forest Capital Management’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-207,060	Closed	-$2.13M	–	1629
2022 Q4	$2.13M	Buy	+207,060	New	+$2.1M	0.52%	53

Other funds holding IQMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Dark Forest Capital Management's IQMD Position: Q1 2023 in Review

Dark Forest Capital Management sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 207,060 shares — an estimated $2.13M sold.

Dark Forest Capital Management first reported a position in IQMD in Q4 2022 and held it in 1 quarter. The position peaked at $2.13M in Q4 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

Dark Forest Capital Management reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Dark Forest Capital Management sold 207,060 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $2.13M.
Dark Forest Capital Management first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q4 2022 and held it in 1 quarter.
Dark Forest Capital Management's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $2.13M in Q4 2022.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Dark Forest Capital Management's 13F filing for Q1 2023, filed 12 May 2023.